Re: Multicenter Prospective Phase II Trial of Neoadjuvant Dose-dense Gemcitabine Plus Cisplatin in Patients with Muscle-invasive Bladder Cancer.

More about this publication

European urology
  • Volume 76
  • Issue nr. 6
  • Pages 870-871
  • Publication date 01-12-2019

This site uses cookies

This website uses cookies to ensure you get the best experience on our website.